You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2012 Q3

This is the 5th quarterly HIV Program report after implementation of the 2011 Integrated Clinical HIV Guidelines in July 2011. A summary of the key achievements between July and September 2012 is provided below:

  • Scale-up of integrated HIV services had reached the following number of sites:

    • 810 static (607 within and 203 outside of health facilities) and 322 outreach HTC sites

    • 641 (static) ART sites

    • 573 PMTCT sites (Option B+)

    • 562 Pre-ART sites

    • 561 sites with HIV-exposed child follow-up

  • 579,509 persons were tested and counselled for HIV and 44,916 (8%) were HIV positive; 226,243 (39%) people tested for the first time. 268,119 (46%) of all tests performed during this quarter took place in August during the 2012 National HIV Testing Week campaign.

  • 119,587 (76%) of 156,778 women at ANC had their HIV status ascertained; 9,837 (8%) of these were HIV positive. 114,897 (87%) of 131,779 women at maternity had their HIV status ascertained; 9,491 (8%) of these were HIV positive.

  • 29,707 patients started ART during this quarter; this is an increase from the previous quarter (26,909) and meets the target of about 30,000 patients to be initiated on ART per quarter under the 2011 PMTCT/ART guidelines.

  • 391,338 patients were alive and on ART by end of September 2012. This exceeds the projected number of ART patients (389,737) for this quarter by 1,601 (0.4%).

  • 62,371 (17%)_ of 362,754__ on first line adult regimens were on ART regimen 5A (tenofovir / lamivudine / efavirenz)

  • 83% of adults and 84% of children were retained alive on ART at 12 months after ART initiation.

  • A total of 10,588 HIV positive pregnant women were on ART: 2,614 (25%) of these were already on ART when getting pregnant and 7,974 (75%) started ART during pregnancy/delivery. 7,754 (97%) of those newly initiated started ART due to Option B+ (in WHO clinical stage 1 or 2) and 220 (3%) due to a low CD4 count and/or WHO clinical stage 3 or 4.

  • An additional 2,689 breastfeeding women started ART due to Option B+ (in WHO clinical stage 1 or 2), bringing the total number started on ART under Option B+ to 10,663.

  • 83% and 79% of women started under Option B+ were retained at 6 and 12 month after ART initiation, respectively.

  • 8,700 (8%) of infants discharged alive from maternity were known to be HIV exposed; 8,109 (93%) of these received ARV prophylaxis. 3,778 (43%) were enrolled in exposed child followup before age 2 months.

  • 8,490 HIV exposed children and 9,161 pre-ART patients enrolled for follow-up in HIV Care Clinics (HCC) during this quarter.

  • 184 health workers were trained and certified in the new integrated PMTCT/ART curriculum during Q3 2012, bringing the total number re-trained in the new guidelines to 4,839. An additional 25 tutors from training institutions were trained in the new curriculum.

  • 171 health workers were trained and certified in PITC; 33 new basic HTC counsellors were trained and certified; 17 new HTC trainers were trained.

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2012
Author
Author Email